v3.20.2
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 18,847 $ 5,789
Restricted cash 312 312
Accounts receivable, less allowance of $3,837 and $2,531 in 2020 and 2019, respectively 3,393 8,760
Inventory 12,592 10,995
Prepaid expenses and other current assets 903 1,163
Total current assets 36,047 27,019
Property, plant, and equipment, net 742 1,193
Goodwill 2,926 2,926
Right of use asset 2,061 276
Other assets 220 433
Total assets 41,996 31,847
Current liabilities:    
Accounts payable 2,592 5,332
Accrued liabilities 4,279 4,744
Deferred revenue, current portion 1,616 2,237
Term loan (net of discount) 12,946 13,466
Total current liabilities 21,433 25,779
Deferred revenue 412 358
Warranty accrual 204 245
Non current term loans 3,140  
Non current operating lease liability 1,859 4
Other liabilities 1,097 1,119
Total liabilities 28,145 27,505
Commitments and contingencies — Note 11
Redeemable preferred stock:    
Series E Preferred stock, par value $0.001 per share; 1,000 shares authorized, 0 and 70 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively   3,965
Stockholders' equity:    
Series F Preferred stock, par value $0.001 per share; 1,000 shares authorized, 1 and 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 141  
Common stock, par value $0.001 per share; 180,000 and 40,000 shares authorized, 93,044 and 31,439 shares issued and 92,999 and 31,439 outstanding as of September 30, 2020 and December 31, 2019, respectively 93 31
Additional paid-in-capital 259,385 235,594
Accumulated other comprehensive loss (534) (701)
Accumulated deficit (245,234) (234,547)
Total stockholders' equity 13,851 377
Total liabilities, redeemable preferred stock and stockholders' equity $ 41,996 $ 31,847

Source